Table 1.
Clinical characteristics of the subjects included in the study
| Characteristic | N (%) | Median [IQR] |
|---|---|---|
| Male sex | 377 (83•6) | |
| Region of origin | ||
| Spain | 236 (81) | |
| Europe | 17 (6) | |
| America | 34 (12) | |
| Africa | 4 (1) | |
| Age at diagnosis | 31 [27-37] | |
| Mode of infection | ||
| MSM | 252 (58) | |
| Heterosexual | 87 (20) | |
| Injecting drug use | 55 (13) | |
| Other | 40 (9) | |
| AIDS events | ||
| Yes | 46 (10) | |
| No | 405 (90) | |
| Zenith viral load (log10 copies/ml plasma) | 4•9 [4•3-5•3] | |
| CD4 nadir (cells/µl) | 273 [159-358] | |
| Time since HIV diagnosis (years) | 13 [7-19] | |
| Viral blips | 0 [0-1] | |
| Virological failures | 0 [0-2] | |
| Tropism | ||
| R5-tropic | 329 (73) | |
| Non-R5 or dual | 93 (21) | |
| Viral subtype | ||
| B | 403 (96) | |
| Non B | 19(4) | |
| Total HIV-1 DNA (copies/106 PBMCs) | 158•5 [78•7-313•4] | |
| At the time of HIV-1 DNA measurements | ||
| Age | 46 [41-51] | |
| Time suppressed (years) | 5•6 [4-8] | |
| CD4 T cells (cells/µl) | 676 [495-891] | |
| CD8 T cells (cells/µl) | 766 [567-1022] | |
| CD4/CD8 ratio | 0.9 [0•6-1•2] |